Skip to main content

J.H. Whitney Equity Partners VII, LLC's Form 4 filing

Aveanna Healthcare Holdings, Inc. (AVAH) · filed Mar 26, 2025

Accession no.
0000950170-25-045583
Filed
Mar 26, 2025
Trade date
Mar 24-25, 2025
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 6 non-derivative transactions. Open-market sales total $2.52K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
J.H. Whitney Equity Partners VII, LLCCIK 000156745910% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 24, 2025Common Stock, $0.01 par valueSSaleDisposed−173$5.63F2−$973.9931,387,986Indirect
Mar 25, 2025Common Stock, $0.01 par valueSSaleDisposed−116$5.64F3−$654.2431,387,870Indirect
Mar 24, 2025Common Stock, $0.01 par valueSSaleDisposed−87$5.63F2−$489.8115,681,774Indirect
Mar 25, 2025Common Stock, $0.01 par valueSSaleDisposed−58$5.64F3−$327.1215,681,716Indirect
Mar 24, 2025Common Stock, $0.01 par valueSSaleDisposed−8$5.63F2−$45.041,451,770Indirect
Mar 25, 2025Common Stock, $0.01 par valueSSaleDisposed−5$5.64F3−$28.21,451,765Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.62 to $5.63. The reporting persons hereby undertake to provide, upon request, to the staff of the Securities and Exchange Commission ("SEC"), the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

Referenced by the price of 3 transactions in Table I.

F3

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.63 to $5.65. The reporting persons hereby undertake to provide, upon request, to the staff of the SEC, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.

Referenced by the price of 3 transactions in Table I.

Remarks

Exhibit List: Exhibit 24 - Confirming Statement

Read the full filing on SEC EDGAR (opens in a new tab)